A detailed history of Trexquant Investment LP transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Trexquant Investment LP holds 186,688 shares of ARWR stock, worth $3.65 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
186,688
Previous 97,470 91.53%
Holding current value
$3.65 Million
Previous $2.53 Million 42.68%
% of portfolio
0.05%
Previous 0.04%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$19.36 - $29.54 $1.73 Million - $2.64 Million
89,218 Added 91.53%
186,688 $3.61 Million
Q2 2024

Aug 13, 2024

BUY
$21.87 - $28.24 $2.13 Million - $2.75 Million
97,470 New
97,470 $2.53 Million
Q2 2023

Aug 11, 2023

BUY
$25.16 - $41.38 $1.41 Million - $2.31 Million
55,893 Added 348.48%
71,932 $2.57 Million
Q1 2023

May 15, 2023

SELL
$23.68 - $38.51 $1.95 Million - $3.17 Million
-82,419 Reduced 83.71%
16,039 $407,000
Q4 2022

Feb 13, 2023

BUY
$28.0 - $40.56 $2.76 Million - $3.99 Million
98,458 New
98,458 $3.99 Million
Q2 2022

Aug 11, 2022

BUY
$27.79 - $50.61 $172,992 - $315,047
6,225 Added 32.2%
25,555 $900,000
Q1 2022

May 13, 2022

BUY
$39.62 - $69.97 $485,543 - $857,482
12,255 Added 173.22%
19,330 $889,000
Q4 2021

Feb 14, 2022

BUY
$58.09 - $82.51 $410,986 - $583,758
7,075 New
7,075 $469,000
Q3 2021

Nov 12, 2021

SELL
$58.38 - $84.96 $447,482 - $651,218
-7,665 Closed
0 $0
Q2 2021

Aug 12, 2021

SELL
$62.15 - $90.32 $781,784 - $1.14 Million
-12,579 Reduced 62.14%
7,665 $635,000
Q1 2021

May 13, 2021

BUY
$61.35 - $90.47 $1.24 Million - $1.83 Million
20,244 New
20,244 $1.34 Million
Q1 2020

May 08, 2020

SELL
$20.56 - $63.12 $551,254 - $1.69 Million
-26,812 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$28.14 - $73.01 $754,489 - $1.96 Million
26,812 New
26,812 $1.7 Million
Q2 2018

Aug 07, 2018

SELL
$6.37 - $14.02 $122,686 - $270,025
-19,260 Closed
0 $0
Q1 2018

May 03, 2018

BUY
$3.72 - $7.64 $71,647 - $147,146
19,260 New
19,260 $139,000

Others Institutions Holding ARWR

About ARROWHEAD PHARMACEUTICALS, INC.


  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.07B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.